March 12, 2026
The LIVERATION clinical trial continues to grow steadily, with 255 patients now recruited across participating centres.
In addition to the increase in patient numbers, the study has also expanded its clinical network with five new hospitals joining the trial, further strengthening the collaborative effort behind the project.
This expansion will help accelerate patient recruitment and reinforce the multicentre nature of the study, bringing together the expertise of medical and surgical teams from different centres across Europe.
More hospitals are also expected to join in the coming months, supporting the continued progress of the trial and its goal of improving treatment options and recovery for people undergoing liver cancer surgery.
We will continue sharing updates as the project moves forward.
The LIVERATION clinical trial continues to grow, reaching 255 recruited patients and expanding its clinical network with five additional hospitals across Europe.